| The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS. | The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
Grigoropoulos I, Tsioulos G, Kastrissianakis A, Shapira S, Green O, Rapti V, Tsakona M, Konstantinos T, Savva A, Kavatha D, Boumpas D, Syrigos K, Xynogalas I, Leontis K, Ntousopoulos V, Sakka V, Sardelis Z, Fotiadis A, Vlassi L, Kontogianni C, Levounets A, Poulakou G, Gaga M, MacLoughlin R, Stebbing J, Arber N, Antoniadou A, Tsiodras S., Free PMC Article | 04/5/2024 |
| Checkpoint CD24 function on tumor and immunotherapy. | Checkpoint CD24 function on tumor and immunotherapy.
Huang S, Zhang X, Wei Y, Xiao Y., Free PMC Article | 03/18/2024 |
| CD24 blockade promotes anti-tumor immunity in oral squamous cell carcinoma. | CD24 blockade promotes anti-tumor immunity in oral squamous cell carcinoma.
Zou KL, Lan Z, Cui H, Zhao YY, Wang WM, Yu GT. | 03/1/2024 |
| Surprising magic of CD24 beyond cancer. | Surprising magic of CD24 beyond cancer.
Wang H, Shi P, Shi X, Lv Y, Xie H, Zhao H., Free PMC Article | 02/6/2024 |
| High Expression and Significance of Siglec10/CD24 in Unexplained Missed Abortion. | High Expression and Significance of Siglec10/CD24 in Unexplained Missed Abortion.
Lin H, Gao L, Huang Y. | 11/30/2023 |
| RARgamma promotes the invasion and metastasis of thyroid carcinoma by activating the JAK1-STAT3-CD24/MMPs axis. | RARγ promotes the invasion and metastasis of thyroid carcinoma by activating the JAK1-STAT3-CD24/MMPs axis.
Zhang FX, Xu P, Zhang LJ, Fan R, Zhang HX, Liu DH, Liu K, Shen DY. | 11/29/2023 |
| CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners. | CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners.
Söhngen C, Thomas DJ, Skowron MA, Bremmer F, Eckstein M, Stefanski A, Driessen MD, Wakileh GA, Stühler K, Altevogt P, Theodorescu D, Klapdor R, Schambach A, Nettersheim D. | 11/28/2023 |
| Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200. | Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200.
Moon SY, Han M, Ryu G, Shin SA, Lee JH, Lee CS., Free PMC Article | 11/2/2023 |
| Soluble CD24 is an inflammatory biomarker in early and seronegative rheumatoid arthritis. | Soluble CD24 is an inflammatory biomarker in early and seronegative rheumatoid arthritis.
Zheng X, Wang P, Song J, Tang Y, Xie Y, Jin X, Zhu D, Fang X, Wei C, Li R, Hu F, Li Z., Free PMC Article | 08/23/2023 |
| Prognostic Implications of CD24, SOX2, and Nanog Expression in Invasive Urothelial Carcinoma. | Prognostic Implications of CD24, SOX2, and Nanog Expression in Invasive Urothelial Carcinoma.
Abdelbary AM, Atwa HA, Elfarargy OM, Qasem ER, Elaidy NF. | 07/13/2023 |
| The biological roles of CD24 in ovarian cancer: old story, but new tales. | The biological roles of CD24 in ovarian cancer: old story, but new tales.
Gu Y, Zhou G, Tang X, Shen F, Ding J, Hua K., Free PMC Article | 07/3/2023 |
| CD24-Siglec interactions in inflammatory diseases. | CD24-Siglec interactions in inflammatory diseases.
Liu Y, Zheng P., Free PMC Article | 06/12/2023 |
| CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence. | CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.
Gómez-Gallegos AA, Ramírez-Vidal L, Becerril-Rico J, Pérez-Islas E, Hernandez-Peralta ZJ, Toledo-Guzmán ME, García-Carrancá A, Langley E, Hernández-Guerrero A, López-Casillas F, Herrera-Goepfert R, Oñate-Ocaña LF, Ortiz-Sánchez E., Free PMC Article | 02/11/2023 |
| CD44(+)/CD24(-) Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study. | CD44(+)/CD24(-) Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study.
Sihombing UHM, Andrijono A, Purwoto G, Gandamihardja S, Harahap AR, Rustamadji P, Kekalih A, Widyawati R, Fuady DR. | 11/5/2022 |
| CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection. | CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection.
Kedarinath K, Fox CR, Crowgey E, Mazar J, Phelan P, Westmoreland TJ, Alexander KA, Parks GD., Free PMC Article | 09/17/2022 |
| CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro? | CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?
Geng R, Harland N, Montes-Mojarro IA, Fend F, Aicher WK, Stenzl A, Amend B., Free PMC Article | 06/11/2022 |
| The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas. | The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas.
Skowron MA, Becker TK, Kurz L, Jostes S, Bremmer F, Fronhoffs F, Funke K, Wakileh GA, Müller MR, Burmeister A, Lenz T, Stefanski A, Stühler K, Petzsch P, Köhrer K, Altevogt P, Albers P, Kristiansen G, Schorle H, Nettersheim D., Free PMC Article | 04/16/2022 |
| Low expression of CD24 is associated with poor survival in colorectal cancer. | Low expression of CD24 is associated with poor survival in colorectal cancer.
Nersisyan S, Ahlers AK, Lange T, Wicklein D, Galatenko A, Bohnenberger H, Elakad O, Conradi LC, Genduso S, Maar H, Schiecke A, Maltseva D, Raygorodskaya M, Makarova J, Schumacher U, Tonevitsky A. | 02/5/2022 |
| Nucleophosmin/B23 promotes endometrial cancer cell escape from macrophage phagocytosis by increasing CD24 expression. | Nucleophosmin/B23 promotes endometrial cancer cell escape from macrophage phagocytosis by increasing CD24 expression.
Lin CY, Tsai CL, Chao A, Lee LY, Chen WC, Tang YH, Chao AS, Lai CH. | 02/5/2022 |
| ZBTB28 inhibits breast cancer by activating IFNAR and dual blocking CD24 and CD47 to enhance macrophages phagocytosis. | ZBTB28 inhibits breast cancer by activating IFNAR and dual blocking CD24 and CD47 to enhance macrophages phagocytosis.
Li L, Gong Y, Tang J, Yan C, Li L, Peng W, Cheng Z, Yu R, Xiang Q, Deng C, Mu J, Xia J, Luo X, Wu Y, Xiang T. | 01/29/2022 |
| ELF5 inhibits the proliferation and invasion of breast cancer cells by regulating CD24. | ELF5 inhibits the proliferation and invasion of breast cancer cells by regulating CD24.
Qu X, Li Q, Tu S, Yang X, Wen W. | 01/22/2022 |
| Cell Surface Glycoprotein CD24 Marks Bone Marrow-Derived Human Mesenchymal Stem/Stromal Cells with Reduced Proliferative and Differentiation Capacity In Vitro. | Cell Surface Glycoprotein CD24 Marks Bone Marrow-Derived Human Mesenchymal Stem/Stromal Cells with Reduced Proliferative and Differentiation Capacity In Vitro.
van de Peppel J, Schaaf GJ, Matos AA, Guo Y, Strini T, Verschoor W, Dudakovic A, van Wijnen AJ, van Leeuwen JPTM., Free PMC Article | 12/18/2021 |
| Co-expression of CD24 and Hsp70 as a prognostic biomarker for lung cancer. | Co-expression of CD24 and Hsp70 as a prognostic biomarker for lung cancer.
Qiao XJ, Gu Y, Du H, Xing ZW, Ma BH, Sun WT, Yu JF, Liu CX. | 10/16/2021 |
| CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy. | CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy.
Ni YH, Zhao X, Wang W. | 08/21/2021 |
| Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma. | Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
Agawa K, Yamashita K, Nakagawa A, Yamada K, Watanabe A, Mukohyama J, Saito M, Fujita M, Takiguchi G, Urakawa N, Hasegawa H, Kanaji S, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y. | 07/31/2021 |